We therefore cannot exclude that the CSTL-mediated induction of effector responses also involves the cleavage of other mediators or that blockage of these mediators by CTSL inhibition, in addition to prevention of C3 cleavage, in patients with arthritis contributes to the observed cytokine reduction. The gene discussed is CTSL; the disease is arthritic joint disease.